90 Results for "

DM-1

" in MedChemExpress (MCE) Product Catalog:
Products (90)

90 Results for "DM-1" in MCE Product Catalog:

Cat. No.: HY-145267
CAS No.: 2406278-81-5
Purity:  99.59%
Target:  

PARP Wnt

Research Areas:  

Cancer

OM-153 is a potent and orally active tankyrase inhibitor with IC50s of 13 nM and 2 nM for tankyrase 1 and tankyrase 2 (TNKS1/2), respectively. OM-153 inhibits luciferase-based Wnt/β-catenin signaling reporter activity with an IC50 value of 0.63 nM. OM-153 shows inhibition of Wnt/β-catenin signaling and proliferation in COLO 320DM .
loading...
    loading...
Cat. No.: HY-132262
CAS No.: 1008106-64-6
Synonyms: IMGN-901; BB-1090
Research Areas:  

Cancer

Lorvotuzumab mertansine is an ADC consisting of a humanized N901 monoclonal antibody against CD56 bound to maytansinoid DM1 via a stable disulfide linker. Lorvotuzumab mertansine has antitumor activity [1].
loading...
    loading...
Cat. No.: HY-100128
CAS No.: 138148-68-2
Purity:  98.16%
Research Areas:  

Cancer

DM1-SMe is an unconjugated form of the Maytansinoid in IMGN901. DM1-SMe is the microtubule inhibitor and can be used as the ADC cytotoxin [1].
loading...
    loading...
Cat. No.: HY-136261
Research Areas:  

Cancer

DM1-(PEG)4-DBCO is a drug-linker conjugate composed of the tubulin inhibitor DM1 (HY-19792) and the linker DBCO-PEG4-Ahx. DM1 is a tubulin inhibitor and an antibody-conjugated maytansinoid; it was developed to overcome the systemic toxicity associated with maytansine and to enhance tumor-specific delivery. DM1-PEG4-DBCO is a click chemistry reagent.
loading...
    loading...
Cat. No.: HY-126693
CAS No.: 2259318-47-1
Purity:  93.25%
Research Areas:  

Cancer

SC-VC-PAB-DM1 is a agent-linker conjugate for ADC with with potent antitumor activity by using DM1 (Mertansine, a tubulin inhibitor) , linked via the ADC linker SC-VC-PAB [1].
loading...
    loading...
Cat. No.: HY-100504
CAS No.: 912569-84-7
Purity:  99.58%
Research Areas:  

Cancer

S-methyl DM1 is a thiomethyl derivative of Maytansine. S-methyl DM1 binds to tubulin with a Kd of 0.93 μM and inhibts microtubule polymerization. S-methyl DM1 potently suppresses microtubule dynamic instability and has anticancer effects [1] .
loading...
    loading...
Cat. No.: HY-P99492
CAS No.: 400010-39-1
Synonyms: SB-408075; huC242-DM1
Cantuzumab mertansine (SB-408075; huC242-DM1), an ADC, is an immunoconjugate of the potent maytansine derivative (DM1 (HY-19792)) and the humanized monoclonal antibody (huC242) directed to CanAg. Cantuzumab mertansine has cytotoxic toward colon cancer cells and has broad antitumor efficacy against a range of CanAg-positive human tumor xenografts [1] .
loading...
    loading...
Cat. No.: HY-132205
CAS No.: 2735803-28-6
Purity:  99.18%
Target:  

Estrogen Receptor/ERR

Research Areas:  

Metabolic Disease

DS45500853 is an estrogen-related receptor α (ERRα) agonist. DS45500853 inhibits the binding between receptor-interacting protein 140 (RIP140) corepressor peptide (10 nM) and GST-ERRα ligand-binding domain (LBD; 1.2 μM) with an IC50 value of 0.80 μM. DS45500853 can be used for the research of metabolic disorders, including type 2 diabetes mellitus (T2DM) .
loading...
    loading...
Cat. No.: HY-132251
CAS No.: 104676-09-7
Purity:  ≥95.0%
Target:  

ADC Linkers

Research Areas:  

Cancer

MCC is non-cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs), such as MCC-DM1 [1].
loading...
    loading...
Cat. No.: HY-W004874
CAS No.: 654-42-2
Synonyms: M-Xylohydroquinone
2,6-Dimethylhydroquinone is a key metabolic intermediate for the Mycobacterium strain DM1 during the degradation of 2,6-dimethylphenol (2,6-xylenol). 2,6-Dimethylhydroquinone can serve as an indicator for early failures in biological treatment systems [1].
loading...
    loading...
Cat. No.: HY-159774
Research Areas:  

Cancer

ADC Control human IgG1-DM1 is the ADC control, which is composed of Human IgG1 kappa, Isotype Control (HY-P99001) and the linker-payload conjugate SMCC-DM1 (HY-101070) [1].
loading...
    loading...
Cat. No.: HY-P99685
CAS No.: 1622327-37-0
Synonyms: IMGN-289; J2898A-SMCC-DM1

Research Areas:  

Cancer

Laprituximab emtansine (IMGN-289) is an immunotoxin targeting HER1. Laprituximab emtansine is an EGFR antibody-drug conjugate (ADC) consisting of the J2898A antibody, DM1 (anti-microtubule agent) and the SMCC thioether linker. Laprituximab emtansine can be used for cancer research [1] .
loading...
    loading...
Cat. No.: HY-114191B
CAS No.: 2988224-31-1
Purity:  98.85%
Target:  

Somatostatin Receptor

Research Areas:  

Metabolic Disease Endocrinology

SSTR5 antagonist 2 hydrochloride is a highly potent, oral active and selective somatostatin (receptor) subtype 5 (SSTR5) antagonist and has potential for the research of type 2 diabetes mellitus (T2DM) .
loading...
    loading...
Cat. No.: HY-143201
CAS No.: 2735803-20-8
Purity:  99.34%
Target:  

Estrogen Receptor/ERR

Research Areas:  

Metabolic Disease

DS20362725 is an estrogen-related receptor α (ERRα) agonist. DS20362725 inhibits the binding between receptor-interacting protein 140 (RIP140) corepressor peptide (10 nM) and GST-ERRα ligand-binding domain (LBD; 1.2 μM) with an IC50 value of 0.6 μM. DS20362725 can be used for the research of metabolic disorders, including type 2 diabetes mellitus (T2DM) .
loading...
    loading...
Cat. No.: HY-132260
CAS No.: 1607824-64-5
Synonyms: IMGN529; Debio 1562

Research Areas:  

Cancer

Naratuximab emtansine (IMGN529) is a CD37-targeted ADC consisting of a humanized IgG1 mAb coupled to the microtubule disruptor DM1. Naratuximab emtansine has high affinity and specificity for CD37, allowing ADC internalization, processing and intracellular release of DM1. Due to its ability to disrupt microtubule assembly, DM1 can subsequently induce cell cycle arrest and apoptosis [1].
loading...
    loading...
Cat. No.: HY-101982A
Purity:  98.18%
Synonyms: (Rac)-Lys-Nε-MCC-DM1
Research Areas:  

Cancer

(Rac)-Lys-SMCC-DM1 ((Rac)-Lys-Nε-MCC-DM1) is the racemate of Lys-SMCC-DM1 (HY-101982). Lys-SMCC-DM1 is a linker-payload component that has the potential to inhibit tubulin polymerization. Lys-SMCC-DM1 is the active metabolite of T-DM1 [1].
loading...
    loading...
Cat. No.: HY-107502
CAS No.: 1260431-28-4
Cryptophycin analog 1 is an ADC payload. Cryptophycin analog 1 shows anticancer activity. Cryptophycin analog 1 displays cell activity an order of magnitude more potent than approved ADC payloads MMAE and DM1 [1].
loading...
    loading...
Cat. No.: HY-177564
CAS No.: 2929240-20-8
Synonyms: Del-zota; AOC 1044
Delpacibart zotadirsen (Del-zota), an antibody oligonucleotide conjugate (AOC), consists of a monoclonal antibody (Delpacibart) (HY-P990051) that binds to the transferrin receptor 1 (TfR1) conjugated to a phosphorodiamidate morpholino conjugate (PMO), Delpacibart zotadirsen is designed to deliver phosphorodiamidate morpholino oligomers (PMOs) to skeletal muscle and heart tissue to specifically skip exon 44 of the dystrophin gene and enable production of near-full length dystrophin. Delpacibart zotadirsen is used for the study of myotonic dystrophy type 1 (DM1) [1].
loading...
    loading...
Cat. No.: HY-147094
CAS No.: 1416792-90-9
Purity:  99.63%
Target:  

ADC Linkers

Research Areas:  

Cancer

vc-PABC-DM1 used to synthesize an ADC molecule based on utilize disulfide linker. vc-PABC-DM1 can be used to explore serum stability [1].
loading...
    loading...
Cat. No.: HY-177454
CAS No.: 2763758-01-4
Research Areas:  

Others

Basivarsen linker is a linker used in HY-177452 Zeleciment basivarsen for coupling a TfR1-binding Fab Zeleciment (HY-P990780) and an antisense oligonucleotide. Zeleciment basivarsen is an antibody-oligonucleotide conjugate (AOC) designed to target mutant nuclear myotonic dystrophy protein kinase (DMPK) RNA for RHase H-mediated degradation to correct splicing. It is used for the study of myotonic dystrophy type 1 (DM1).
loading...
    loading...